Literature DB >> 19474353

Renal toxicity of therapeutic drugs.

R John1, A M Herzenberg.   

Abstract

A number of therapeutic agents can adversely affect the kidney, resulting in tubulointerstitial, glomerular or vascular disease. Drug-induced tubulointerstitial nephritis and acute tubular necrosis are common, and are often cause by antibiotics or non-steroidal anti-inflammatory drugs. Drug-induced glomerular and vascular disease is relatively rare. This review describes the morphological patterns of drug-induced disease in the kidney. The histopathological changes are often similar to disease that is idiopathic or due to other causes, so that awareness and clinical correlation are most helpful to arrive at the aetiology.

Entities:  

Mesh:

Year:  2009        PMID: 19474353     DOI: 10.1136/jcp.2008.058271

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  26 in total

1.  Rapidly deteriorating kidney function in a young man previously diagnosed with membranous nephropathy.

Authors:  Giovani Gadonski; Carlos E Poli-de-Figueiredo; Fernando C Fervenza; Ajay K Singh; Fernando M Tettamanzy; Ivan C F Antonello; Domingos O d'Avila
Journal:  Nephron Clin Pract       Date:  2010-05-07

Review 2.  Mechanisms of antimicrobial-induced nephrotoxicity in children.

Authors:  Kevin J Downes; Molly Hayes; Julie C Fitzgerald; Gwendolyn M Pais; Jiajun Liu; Nicole R Zane; Stuart L Goldstein; Marc H Scheetz; Athena F Zuppa
Journal:  J Antimicrob Chemother       Date:  2020-01-01       Impact factor: 5.790

3.  Preclinical models for interrogating drug action in human cancers using Stable Isotope Resolved Metabolomics (SIRM).

Authors:  Andrew N Lane; Richard M Higashi; Teresa W-M Fan
Journal:  Metabolomics       Date:  2016-06-29       Impact factor: 4.290

Review 4.  Acute Kidney Injury Subsequent to Cardiac Surgery.

Authors:  Robert S Kramer; Crystal R Herron; Robert C Groom; Jeremiah R Brown
Journal:  J Extra Corpor Technol       Date:  2015-03

5.  Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease.

Authors:  Jonathan Wang; Jacqueline J Masehi-Lano; Eun Ji Chung
Journal:  Biomater Sci       Date:  2017-07-25       Impact factor: 6.843

6.  Targeted therapy of colorectal neoplasia with rapamycin in peptide-labeled pegylated octadecyl lithocholate micelles.

Authors:  Supang Khondee; Emily F Rabinsky; Scott R Owens; Bishnu P Joshi; Zhen Qiu; Xiyu Duan; Lili Zhao; Thomas D Wang
Journal:  J Control Release       Date:  2014-12-04       Impact factor: 9.776

7.  Protective effect of indomethacin in renal ischemia-reperfusion injury in mice.

Authors:  Sheng-hong Zhu; Li-jia Zhou; Hong Jiang; Rong-jun Chen; Chuan Lin; Shi Feng; Juan Jin; Jiang-hua Chen; Jian-yong Wu
Journal:  J Zhejiang Univ Sci B       Date:  2014-08       Impact factor: 3.066

Review 8.  Advances in the Pharmacogenomics of Adverse Drug Reactions.

Authors:  Susannah L Collins; Daniel F Carr; Munir Pirmohamed
Journal:  Drug Saf       Date:  2016-01       Impact factor: 5.606

9.  Traumeel - an emerging option to nonsteroidal anti-inflammatory drugs in the management of acute musculoskeletal injuries.

Authors:  Christian Schneider
Journal:  Int J Gen Med       Date:  2011-03-25

10.  Salvianolic Acid B, a potential chemopreventive agent, for head and neck squamous cell cancer.

Authors:  Yuan Zhao; Yinhan Guo; Xinbin Gu
Journal:  J Oncol       Date:  2010-12-20       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.